When heart cells are damaged by a stress chemical, a diabetes drug called dapagliflozin helps calm the damage by lowering harmful chemicals and bringing back a protective enzyme.

6

Pro

0

Against

Evidence from Studies

Supporting (1)

6

Community contributions welcome

6

Dapagliflozin attenuates post-infarction fibrosis via cardiomyocyte protection and fibroblast inhibition.

Cohort Study

Animal

2025 Dec 15

The study found that dapagliflozin helps protect heart cells from damage caused by a stress chemical by reducing harmful molecules and boosting the cell’s natural defense system — just like the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Dapagliflozin attenuates post-infarction fibrosis via cardiomyocyte protection and fibroblast inhibition.

Score: 6

DOI: 10.1016/j.lfs.2025.124083

Similar Assertions

A diabetes drug called dapagliflozin may help protect heart blood vessels from damage caused by temporary lack of oxygen and then sudden return of blood flow, by calming down a harmful enzyme, keeping a key protein from getting damaged, and helping cells manage calcium properly — which keeps the vessel lining intact and stops cells from dying.

8

0

71%

When heart blood vessel cells are stressed by low oxygen and then get oxygen back, a diabetes drug called dapagliflozin helps them heal better by calming down harmful stress and fixing their internal calcium levels.

8

0

71%